PROM1 and lung carcinoma: A study that histologically analyzed lung tissue from lung cancer patients stated that CD133+ endothelial progenitor cells contributed to neovascularization and tumor growth vascular damage was not reported after using CD133 targeted constructs but data implicate the potential of capillary complications after administration.